Gabriele Caviglioli
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Correction: Chronic administration of Metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 20, 2026
Chronic administration of metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 01, 2025
Medicine Shortages: An Algorithm for Evaluating the Substitution with Equivalent or Alternative Products.
Journal: Healthcare (Basel, Switzerland)
Published: March 21, 2025
A Novel Hydrogel Sponge for Three-Dimensional Cell Culture.
Journal: Pharmaceutics
Published: September 20, 2024
Unveiling Niaprazine's Potential: Behavioral Insights into a Re-Emerging Anxiolytic Agent.
Journal: Biomedicines
Published: July 18, 2024
Human glioblastoma-derived cell membrane nanovesicles: a novel, cell-specific strategy for boron neutron capture therapy of brain tumors.
Journal: Scientific reports
Published: April 10, 2024
Phytochemicals and Cancer Treatment: Cell-Derived and Biomimetic Vesicles as Promising Carriers.
Journal: Pharmaceutics
Published: April 06, 2023
Development and validation of a GC-MS method for determination of metformin in normal brain and in glioblastoma tissues.
Journal: Journal of pharmaceutical and biomedical analysis
Published: February 27, 2023
Boron Vehiculating Nanosystems for Neutron Capture Therapy in Cancer Treatment.
Journal: Cells
Published: November 02, 2022
Last Updated: 09/26/2026